Claudio Nessi joined NeoMed Management in 2001 and became a Partner in 2004. He has over 10 years experience of venture capital investing in healthcare in Europe and the US. Claudio heads NeoMed’s operations in Switzerland.
Previously Claudio was a Venture Partner with Genevest Consulting Group SA, Geneva. He has academic research experience in molecular biology from the Max Planck Institute and the University of Connecticut.
Claudio has been a board member of Axovan AG, Endosense SA, Kuros BioSurgery AG and PregLem SA and currently serves on the board of directors of Arsanis, Inc., Avitide, Inc., Creabilis SA and GenKyoTex SA.
Claudio Nessi holds an MBA from Erasmus University, the Netherlands, and is a Ph.D. degree in Genetics from the University of Pavia, Italy.